Back to results

Massachusetts Institute of Technology

Commercial technology transfer optimization for drug substance process development

Abstract

dc:description.abstract

Commercial technology transfer for biopharmaceuticals is the process of transferring process and product knowledge between process development and manufacturing organizations to achieve product realization. This process often occurs before phase 3 of clinical trials, where speed and agility are critical for preventing delays in clinical programs and ensuring commercial site readiness ahead of regulatory approval. As the market is evolving with new modalities and subsequent operational challenges, there is a heightened need to optimize the technology transfer process to sustain growth of products entering an organization's pipeline. This graduate research project seeks to understand the business process workflow of commercial tech transfer and characterize its dynamics using discrete event simulation. Through this quantitative technique of business process modeling, knowledge regarding process bottlenecks and system constraints were revealed, leading to the identification of operational efficiencies which suggest a potential 19.5% reduction in lead times and 31.3% increase in organizational capacity. Furthermore, this work provides a platform for predicting program timelines and resource needs based on preliminary transfer requirements. These predictions can be updated in a Bayesian fashion for real-time project scheduling and capacity planning.

Degree

thesis:*
Name thesis:degree_name
Master
Department dc:contributor.department
Sloan School of Management
Grantor dc:publisher
Massachusetts Institute of Technology
Year dc:date.issued
2019

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Doucette, Hillary.
Advisor dc:contributor.advisor
  • Richard D. Braatz and Thomas Roemer.

Subjects

dc:subject × 3

Rights

dc:rights
Statement dc:rights
  • MIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission.
Language dc:language.iso
eng

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/1721.1/122594
OAI identifier oai:identifier
oai:dspace.mit.edu:1721.1/122594

Chain of custody

source
Harvested from
MIT
Base URL
dspace.mit.edu/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
citation

Doucette, Hillary.. Commercial technology transfer optimization for drug substance process development. Massachusetts Institute of Technology, 2019. https://hdl.handle.net/1721.1/122594